Literature DB >> 15310471

The immune response to Epstein-Barr virus.

Margaret F C Callan1.   

Abstract

Epstein-Barr virus is a gammaherpes virus that establishes persistent infection in the majority of humans. Despite the potent oncogenic potential of the virus it is relatively rarely associated with malignant disease. This review focuses on the cellular immune responses that successfully control Epstein-Barr virus infection in most individuals.

Entities:  

Mesh：

Year:  2004        PMID： 15310471     DOI： 10.1016/j.micinf.2004.04.014

Source DB:  PubMed          Journal:  Microbes Infect        ISSN： 1286-4579            Impact factor:   2.700


  15 in total

Review 1.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

2.  The use of dried blood spot sampling in the national social life, health, and aging project.

Authors:  Sharon R Williams; Thomas W McDade
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-02-25       Impact factor: 4.077

3.  Identification of major histocompatibility complex class II-restricted antigens and epitopes of the Epstein-Barr virus by a novel bacterial expression cloning approach.

Authors:  Slavoljub Milosevic; Uta Behrends; Dinesh Adhikary; Josef Mautner
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

4.  Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load.

Authors:  John C Tilton; Marlise R Luskin; Alison J Johnson; Maura Manion; Claire W Hallahan; Julia A Metcalf; Mary McLaughlin; Richard T Davey; Mark Connors
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

5.  HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.

Authors:  Henrik Hjalgrim; Klaus Rostgaard; Paul C D Johnson; Annette Lake; Lesley Shield; Ann-Margaret Little; Karin Ekstrom-Smedby; Hans-Olov Adami; Bengt Glimelius; Stephen Hamilton-Dutoit; Eleanor Kane; G Malcolm Taylor; Alex McConnachie; Lars P Ryder; Christer Sundstrom; Paal Skytt Andersen; Ellen T Chang; Freda E Alexander; Mads Melbye; Ruth F Jarrett
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-22       Impact factor: 11.205

6.  Involvement of Epstein-Barr virus (EBV)-encoded latent membrane protein (LMP)-1 in the potentiation of C epsilon mRNA expression in human tonsil-derived cells.

Authors:  Shigeto Ohta; Kazuhiko Hanashiro; Masanori Sunagawa; Tetsuya Tono; Mikio Suzuki; Tadayoshi Kosugi
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-07       Impact factor: 2.503

7.  Cytotoxic CD4+ T cell responses to EBV contrast with CD8 responses in breadth of lytic cycle antigen choice and in lytic cycle recognition.

Authors:  Heather M Long; Alison M Leese; Odette L Chagoury; Shawn R Connerty; Jared Quarcoopome; Laura L Quinn; Claire Shannon-Lowe; Alan B Rickinson
Journal:  J Immunol       Date:  2011-05-27       Impact factor: 5.422

8.  A mutation in X-linked inhibitor of apoptosis (G466X) leads to memory inflation of Epstein-Barr virus-specific T cells.

Authors:  E Lopez-Granados; M Stacey; A-K Kienzler; S Sierro; C B Willberg; C P Fox; S Rigaud; H M Long; A D Hislop; A B Rickinson; S Patel; S Latour; P Klenerman; H Chapel
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

9.  MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response.

Authors:  Heather M Long; Odette L Chagoury; Alison M Leese; Gordon B Ryan; Eddie James; Laura T Morton; Rachel J M Abbott; Shereen Sabbah; William Kwok; Alan B Rickinson
Journal:  J Exp Med       Date:  2013-04-08       Impact factor: 14.307

10.  Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.

Authors:  Caroline Besson; Sophie Roetynck; Fionnuala Williams; Laurent Orsi; Corinne Amiel; Catherine Lependeven; Guillemette Antoni; Olivier Hermine; Pauline Brice; Christophe Ferme; Patrice Carde; Danielle Canioni; Josette Brière; Martine Raphael; Jean-Claude Nicolas; Jacqueline Clavel; Derek Middleton; Eric Vivier; Laurent Abel
Journal:  PLoS One       Date:  2007-05-02       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.